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and angiogenic gene profile
Dana R Obery*, Patricia A Rayman, Yu Yang, Jennifer S Ko, James H Finke
From Society for Immunotherapy of Cancer 28th Annual Meeting
National Harbor, MD, USA. 8-10 November 2013
Myeloid derived suppressor cells (MDSC) are detected at
elevated levels in the peripheral blood mononuclear cells
(PBMC) of human renal cell carcinoma (RCC) patients
and have been shown to mediate tumor growth by pro-
moting angiogenesis and immune suppression (Zea et al.,
2005, Ko et al., 2009). Granulocytic-MDSCs (G-MDSCs),
the dominant population in RCC patients, have been
shown to suppress T-cell function in RCC patients (Rodri-
guez et al., 2009; Schmeilau and Finn, 2001; Zea et al.,
2005). However, less is known regarding the role of neu-
trophils in promoting tumor growth in RCC patients and
their relationship to G-MDSC. In this study we compared
the suppressive and angiogenic profile of neutrophils from
RCC patients to those of normal donors and the impact
that RCC conditioned media has in altering neutrophils
normal function. We showed that IFNg production of
T-cells stimulated with anti-CD3/antiCD28 antibodies
(n=4) was suppressed by neutrophils pretreated with SK-
RC-26b tumor supernatant (TCM) when compared to
neutrophils not exposed to TCM. Further experiments
showed that neutrophils from RCC patients had increased
expression compared to normal healthy donor neutro-
phils of genes Vegfa (15.28 fold increase), Vegfb (10.84
fold increase), Tgfb1 (3.31 fold increase), IL10 (23.45 fold
increase), IDO1 (4.60 fold increase), Nox1 (9.33 fold
increase), and Prokr2 (4.14 fold increase) utilizing custom
pro-angiogenic and immunosuppressive RT-PCR arrays
(n=4). Furthermore, human angiogenesis Proteome Profile
Arrays (n=2) were performed comparing RCC patient and
normal healthy donor neutrophils and exhibited an
increased level of Activin A (94.5% increase), Angiogenin
(70% increase), Angiostatin/plasminogen (56% increase),
IGFBP-1 (188% increase), IGFBP-2 (263% increase),
TGF-B1 (157.5% increase), Pentraxin 3 (140% increase),
PD-ECGF (184.5% increase), Serpin E1 (196% increase),
and Serpin F1 (114.5% increase) in RCC patient neutro-
phils. Normal neutrophils cultured with ACHN tumor
supernatant for 18 hours (n=2) had up-regulation of pro-
teins CXCL16 (111% increase), FDF-7 (82% increase),
Serpin E1 (470.5% increase), and uPA (198.5% increase)
when compared to normal healthy donor’s neutrophils
cultured 18 hours in media. In summary, we observed up-
regulation of several pro-angiogenic/immunosuppressive
genes in RCC patient neutrophils, suggesting RCC patient
neutrophils may promote tumor escape. In addition, the
normal healthy donor neutrophils cultured with ACHN
tumor supernatant produces several angiogenic proteins
suggesting the tumor microenvironment could be provid-
ing factors to mediate these angiogenic functions in RCC
patient’s neutrophils.
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